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A B S T R A C T
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic disorder with diffuse extra-skeletal bone for-
mation. The genetic mutation responsible for FOP has recently been discovered and is connected with excessive activa-
tion of bone morphogenetic protein receptor. This disease usually begins with typical ossification pattern in early child-
hood, causing increasing disability and making patients totally disabled by the age of 30. Ectopic ossification develops
spontaneously and can be triggered by any trauma and even intramuscular injections. The symptoms of FOP are often
misdiagnosed as cancer, causing unnecessary biopsies, which can precipitate further progressive heterotopic ossification.
There is no effective treatment for this severe condition. Radiotherapy can be helpful in impeding ossification, although
the strict evidence for that is lacking. There are only two reports in the literature referring to the use of radiotherapy in
treatment of FOP. Herein, we present a 35-year-old patient successfully treated with small doses of fractionated radio-
therapy in several courses. This case indicates that radiotherapy can be useful in treating patients with FOP.
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Introduction
Fibrodysplasia ossificans progressiva (FOP), also known
as myositis ossificans progressiva, is an extremely rare
disease of the connective tissue. It affects approximately
one in two million individuals, assuming there are only
300 known patients worldwide. Main characteristics of
FOP are congenital skeletal malformations of the great
toes and progressive heterotopic ossification in specific
anatomic patterns leading to early disability1. Although
genetic transmission is autosomal dominant, most cases
are sporadic and arise as a result of a spontaneous new
mutation2. During childhood new bone is being formed
within soft connective tissue, such as skeletal muscle,
tendon, and ligaments, making skeletal elements fuse
with normal skeletal bone. Before being ossified, soft tis-
sue gets swelled and inflamed. Heterotopic bone forma-
tion is episodic, with ossification generally occurring in a
predictable sequence, starting in the upper back and
neck region. This disease is progressive leading to an
early disability due to contractures and joint fusions.
Natural progressive course of the disease can be precipi-
tated by soft tissue injury or any minor trauma, such as in-
tramuscular injections. Furthermore, mandibular blocks
for dental work, muscle fatigue, blunt muscle trauma
from bumps, bruises and falls may promote heterotopic
bone formation at the site of injury and immobility. At-
tempts of doing biopsy or surgically removing hetero-
topic bone may risk provoking sudden and painful new
bone growth3. There is no known effective treatment for
FOP. Radiotherapy treatment might have some thera-
peutic effect in FOP although there is no firm evidence
for that and the literature referring to radiotherapeutic
treatment of patients with FOP is extremely scarce.
Case report
A 35-year-old female patient was diagnosed with FOP
at age of four, when her parents had noticed a red, pain-
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ful gristle on her back, turning into a bone in few days.
Till the age of 8, she was able to walk erected, but after-
wards the back bone progressively got crooked, so by the
age of 10 she could not erect herself any more. The spine
became immobile due to ossification of the paravertebral
muscles. On several occasions in her teenage period, she
was treated with etidronate and peroral corticosteroid
therapy (metilprednisolone), with noticeable results, lea-
ving her without formation of new ossification foci for
two years.
At the age of 25, the disease progressed in her right
upper arm and both knees. The masticatory muscles
were also affected, causing disability to open the mouth
and consequential eating difficulties. The anecdotal fact
is that the patient noticed subjective improvement of
painful ossification symptoms after the X-ray examina-
tion of right upper arm and both knees, which revealed
the onset of heterotopic ossification of the soft tissue
around the joints.
The decision was made to treat the patient with radio-
therapy for the first time in the course of her disease, af-
ter an informed consent was obtained. She received 10
Gy delivered in 5 fractions on the right upper arm and 8
Gy, delivered in two fractions, on both knees. Checkups
after the treatment revealed a good long-term outcome:
in the region of her right upper arm there was no further
ossification radiologically proven for the next four years,
while the radiographs of both knees revealed no further
ossification within the 10 years’ follow-up.
On the grounds of such favourable radiation response
in patient, the decision was made to treat the patient
with radiotherapy in case of trauma or onset of signs of
ossification in particular region. The treatment decisions
regarding the patient were made in multidisciplinary set-
ting.
Two years later, flare-ups appeared on extremities,
causing ossification around joints of hands and legs with
consequently increasing immobility. Based on clinical
status and computerised tomography (CT) findings, which
revealed active heterotopic ossification in the region of
proximal part of her right upper arm and distal part of
her right upper leg, the radiation therapy was indicated.
The patient received 2 Gy, delivered in two fractions on
previously not irradiated, remaining part of her right up-
per arm and the same dose on the distal part of her right
upper leg. Radiotherapy was also applied on the right,
anterior part of her neck with 6 Gy delivered in 6 frac-
tions, based on clinical finding of developing an initial
heterotopic ossification.
At the moment radiotherapy was applied, the patient
reported immediate remission of symptoms.
Control CT checkups of irradiated regions, performed
biannually through the following four years, revealed
stationary findings of heterotopic ossification. Because of
respiratory limiting ossification of the right thoracic
wall, the patient received radiotherapy of 4 Gy, delivered
in 4 fractions on the ossificating area of right thorax.
Two months later the radiation was delivered on the
right infraclavicular area, due to the onset of active dis-
ease in that region. The patient received 4 Gy delivered
in 4 fractions. Chest X ray checkups had been performed
regularly and the last that was done 3 years ago revealed
no further progression of the disease in the region of the
right thoracic wall, but the active ossification was clini-
cally and radiologically confirmed on the left anterior
part of the neck. The last radiotherapy treatment was
performed at the age of 34, on the affected area of neck,
with dose of 3 Gy delivered in 3 fractions, in order to pre-
vent ossification around larynx and to keep the airway
intact. The patient was discharged from radiotherapy
treatment with an immediate subjective improvement of
symptoms. At the follow-up visits that were made six
months and one year after the treatment, the clinical and
radiological examinations revealed no ossification found
in treated region, also with no functional lesions.
Regarding the timing of symptoms’ improvement, the
patient reported a clinical amelioration already within
the first three days after the commencing of radiother-
apy, throughout all radiotherapy courses.
During the last radiotherapy course the patient was
34-year-old, and had developed multiple joint contra-
ctures. Chest X-ray revealed deformation of all bony
structures with osseous intercostal bridging (Figure 1).
Abdominal CT was performed due to the onset of hete-
rotopic ossification in abdominal wall. Definitive skeletal
deformation and extensive heterotopic ossification were
clearly demonstrated, but the positive impact of radio-
therapy on both knees and right shoulder has remained
till nowadays (Figure 2).
Discussion
The misdiagnosis of FOP approaches 90 per cent of
affected individuals worldwide. FOP is commonly mis-
diagnosed as aggressive juvenile fibromatosis, lymphe-
dema, or soft tissue sarcoma. Seven patients, out of those
misdiagnosed with cancer, received radiotherapy but
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Fig. 1. Chest X-ray indicating thorax deformation, orthotopic an-
kylosis of the costovertebral joints, ossification of intercostal
muscles and spine kyphoscoliosis.
there has been no mention of the outcome4. Most pa-
tients with FOP are confined to a wheelchair by the third
decade of life, and require lifelong assistance in perform-
ing activities of daily living. The median age of survival is
approximately 41 years, and death often results from
complications of thoracic insufficiency syndrome5.
The genetic mutation leading to FOP has recently
been discovered and linked to chromosome 2q23-24. The
analysis revealed heterozygous mutation in the glycine-
-serin (GS) activation domain of ACVR1, a bone morpho-
genetic protein (BMP) type 1 receptor6. Additional muta-
tions have been identified in the GS-domain and kinase
domain of ACVR1 in individuals with atypical forms of
FOP7. Protein homology modelling of the mutated recep-
tor predicts destabilization of the glycine-serine (GS) ac-
tivation domain, consistent with an overactive BMP sig-
nalling pathway as the underlying cause of the ectopic
chondrogenesis, osteogenesis, and joint fusions seen in
FOP8.
Bone morphogenetic proteins (BMPs) constitute the
group of growth factors involved in pivotal morphoge-
netic signalling, orchestrating tissue architecture through-
out the body.
Moreover, BMPs have an important role in many
physiological and pathophysiological processes, such as
regeneration, repair, development of specific tissues and
even a protective role against fibrotic processes in infla-
mation9. In addition with the fact that BMPs have ability
to induce ectopic bone formation, the novel studies indi-
cate that their expression in prostate cancers have been
linked specifically with the tumour progression to bone
and the development of osteosclerotic metastases10.
Any kind of surgery in patients with FOP is harmful;
it causes disease progression and should be avoided (ex-
cept in emergencies). There are no established treat-
ments for FOP and no clinical trials to assess the efficacy
of any potential therapy. Since there is no effective treat-
ment for FOP, it is of crucial importance to avoid any
kind of soft tissue trauma, iatrogenic or accidental. Early
diagnosis an avoidance of trauma are the basic principles
of dealing with these patients.
Knowing the progressive nature of disease, we can as-
sume further progression in the future. However, in our
patient the radio- therapy, periodically undertaken dur-
ing a relatively long period of ten years, helped with
acute flare-ups and halted the disease progression. At
first application of radiotherapy our patient was 25 year
old and at last session of radiotherapy she was 34. It is
ten year follow up from the first radiotherapy treatment.
This patient received radiotherapy treatment on domi-
nant sites of pathologic ossification (except on spine),
with no side-effects. The leading positive effect of radio-
therapy remained on the right shoulder and both knees
with preserved limited range of motion.
It is well known that radiotherapy is effective and
safely applied for post-traumatic forms of heterotopic os-
sification, following spinal injuries, postoperative forma-
tion of new bone and even for the prophylaxis of ossifica-
tion at the time of bone surgery11. It can be deduced that
there is a clinical and scientific background regarding
use of radiotherapy in conditions of heterotopic ossifica-
tion. But there is no obvious reason why radiotherapy
should not be applied in patients with FOP, taking into
account its similar patophysiology with other forms of
heterotopic ossification.
The rationale for use of radiotherapy in FOP clearly
exists. The patient was informed about the possible risk
of radiotherapy and treatment failure, and gave infor-
med consent. This case might be considered as a unique
case of successful radiotherapy in patient with FOP, spe-
cially considering that radiotherapy was delivered in
many sessions, eight exactly, producing durable thera-
peutic response.
We have performed a search of PubMed database and
found only two case reports in the literature on radio-
therapy treatment of such patients, with a relatively
short follow-up12,13.
One refers to radiotherapy accompanied by indome-
thacin therapy after heterotopic bone excision in 18-
-year-old patient with the follow-up of one year. In this
case, radiotherapy and indomethacin were given as a
common prevention of ossification, assuming the regular
onset of heterotopic ossification after bone surgery. Only
a small amount of heterotopic bone formation was radio-
logically found at the operative site, one year after the
surgery. The other is a case of radiotherapy reducing the
femoral nerve compression in FOP patient with clinical
and radiological improvement, revealed two months af-
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Fig. 2. Computed tomography maximum intensity projection
(MIP) image demonstrating extensive irregular ossifications in
lumbar subcutaneous fat, along right gluteal muscles from iliac
crest to hip and in left thigh adductor muscles.
ter the procedure. In both cases a single fraction irradia-
tion was performed (7 Gy and 10 Gy respectively) and ra-
diotherapy produced noticeable effect.
Except for these two anecdotal reports, there is no
clear evidence the radiotherapy is effective in patients
with FOP. However, there might be a rationale for small
doses of radiotherapy treatment in FOP, since radiother-
apy is efficient in proliferating cell kill and can induce
bone remodelling, with no serious side-effects. Those two
elements are crucial in pathophysiology of FOP lessions14.
Since radiotherapy is not an established treatment for
FOP, the most effective fractionation schedule is un-
known. Using the evidence-based data, from a large body
of literature regarding radiotherapy administered for
preventing heterotopic ossification following total hip
arthroplasty, it can be found that a total dose and dose
fractionation schedule are still a matter of debate, with
no specific treatment regime advocated15.
Conclusion
As there is no effective treatment for FOP and bone
surgery is contraindicated, radiation therapy should be
considered, in specific cases, as the treatment of choice
for patients with FOP, especially taking into account that
radiotherapy is well tolerated treatment with no side-ef-
fects. This treatment should be tested in larger number
of FOP patients to evaluate its actual efficacy.
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RADIOTERAPIJA U LIJE^ENJU PROGRESIVNE OSIFICIRAJU]E FIBRODISPLAZIJE:
PRIKAZ SLU^AJA I PREGLED LITERATURE
S A @ E T A K
Fibrodysplasia ossificans progressiva (FOP) vrlo je rijetki genetski poreme}aj kojeg karakterizira difuzno ekstraske-
letalno stvaranje kosti. Genetska mutacija odgovorna za nastanak FOP-a je nedavno otkrivena i povezana je s preko-
mjernom aktivnosti receptora za ko{tani morfogenetski protein. Ta bolest obi~no po~inje u ranom djetinjstvu tipi~nim
na~inom oko{tavanja, uzrokuju}i progresivnu onemo}alost, tako da bolesnici postaju potpuni invalidi do dobi od 30
godina. Ektopi~no oko{tavanje se razvija spontano i mo`e biti uzrokovano bilo kakvom vrstom traume, ~ak i intramus-
kularnim injekcijama. Simptomi FOP-a se ~esto krivo dijagnosticiraju kao rak, uzrokuju}i nepotrebne biopsije, {to pre-
cipitira daljnje opse`no ektopi~no oko{tavanje. Nema u~inkovitog lije~enja za ovo te{ko stanje. Radioterapija mo`e biti
korisna u usporavanju oko{tavanja, iako nema ~vrstih dokaza za to. Postoje samo dva literaturna izvje{taja koji se
odnose na kori{tenje radioterapije u lije~enju FOP-a. U ovom radu prikazuje se slu~aj 35-godi{nje bolesnice koja je
uspje{no lije~ena malim dozama frakcionirane radioterapije. Ovaj slu~aj upu}uje na ~injenicu da radioterapija mo`e biti
korisna u lije~enju bolesnika sa FOP-om.
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